Met its match.

An exploratory analysis of the large MA.32 trial suggests adding metformin to adjuvant chemo for HER2+ breast cancer can improve disease-free and even overall survival, while an accompanying editorial points out this should be even more marked when applied to women with metabolic syndrome, something that can itself be induced by adjuvant chemo. | Goodwin, JAMA 2022 & Mortimer, JAMA Oncol 2022


Popular Posts